曲安奈德相关黄斑病变的临床发现
该回顾性、干预性、非对照、单中心病例系列描述了玻璃体腔注射曲安奈德(IVTA)后超过1年出现晶状体视网膜病变的患者特征。共纳入16例患者18只眼,IVTA后平均随访5.8年(范围1.1-9.2年),发现视网膜前晶体具有折射性、血管造影不可见、缓慢溶解和移动、偶呈环形分布,光学相干断层扫描确认位于视网膜前和/或玻璃体下,结论认为这些晶体可存在多年且表现非病理性。
要点
- IVTA后黄斑晶体可持续数年,平均随访5.8年(范围1.1-9.2年)。
- 晶体位于视网膜前或玻璃体下,荧光素和吲哚菁绿血管造影不可见。
- 晶体可缓慢溶解和移动,偶呈环形分布,反映玻璃体黄斑囊,表现非病理性。
核心结论
- IVTA后黄斑晶体可存在数年,位于视网膜前或玻璃体下,血管造影不可见,可缓慢溶解和移动,偶呈环形分布反映玻璃体黄斑囊,表现非病理性。
研究设计与样本
- 回顾性、干预性、非对照、单中心病例系列,纳入IVTA后出现持续超过1年的晶状体视网膜病变的患者。
主要发现
- 共纳入16例患者18只眼,IVTA后平均随访5.8年(范围1.1-9.2年)。
- 晶体具有折射性,荧光素和吲哚菁绿血管造影不可见,可缓慢溶解和移动,偶呈环形分布。
- 光学相干断层扫描确认晶体位于视网膜前和/或玻璃体下。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To describe a crystalline retinopathy observed in patients greater than 1 year after intravitreal injection of triamcinolone acetonide (IVTA). METHODS: A retrospective, interventional, noncomparative, single-center case series of patients who received IVTA and developed subsequent crystalline retinopathy lasting greater than 1 year after injection. RESULTS: Eighteen eyes of 16 patients in which preretinal crystals were observed >1 year after IVTA were included in the study, with a mean follow-up (range) of 5.8 years (1.1-9.2) after IVTA. The crystals were refractile, not visible on fluorescein nor indocyanine green angiography, exhibited slow dissolution and movement, and were occasionally distributed in a circular fashion. Optical coherence tomography confirmed the preretinal and/or subhyaloid location of crystals. CONCLUSION: Macular crystals can persist for years after IVTA. The crystals localize to the preretinal or subhyaloid space, are angiographically silent, can exhibit slow dissolution and movement, may be distributed in a circular fashion reflecting the bursa premacularis, and appear nonpathologic.
引用
- Fine HF, Reshef ER, Prenner JL, et al. CLINICAL FINDINGS IN TRIAMCINOLONE-ASSOCIATED MACULOPATHY. Retina. 2019. PMID: 29293206. doi:10.1097/IAE.0000000000002007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。